NCT05450718View on ClinicalTrials.gov

Low-dose Buprenorphine Initiation for Opioid Use Disorder

PHASE4RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 11, 2024

Primary Completion Date

March 17, 2027

Study Completion Date

June 30, 2027

Conditions
Opioid Use Disorder
Interventions
DRUG

buprenorphine-naloxone

Low-dose initiation of buprenorphine-naloxone protocol

DRUG

buprenorphine-naloxone

Standard clinical guidelines for a two-day buprenorphine-naloxone initiation

Trial Locations (1)

10467

RECRUITING

Montefiore Medical Center, The Bronx

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Montefiore Medical Center

OTHER

NCT05450718 - Low-dose Buprenorphine Initiation for Opioid Use Disorder | Biotech Hunter | Biotech Hunter